Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic

Gregory Dwyer, MPH; Adebola Popoola, JD, MPH, MBS; Naomi Seiler, JD; Nicole Therrien, PharmD, MPH; Aaron Karacuschansky, MPH; Erika Fulmer, MHA; Katie Horton, JD, RN, MPH


Prev Chronic Dis. 2022;19(3):e10 

In This Article


The global disruption caused by the COVID-19 pandemic prompted policy makers, clinicians, and patients to consider how health care professionals deliver care, particularly as traditional avenues for care were overwhelmed with the COVID-19 response. Long before the pandemic, many pharmacy partners championed pharmacist involvement in providing chronic disease management,[1] a task made even more critical by the pandemic.[2] Given their proximity[3] to Americans, community pharmacists are well-positioned to fill gaps in chronic disease management services. Researchers sought to explore the role of community pharmacists in providing chronic disease management services to identify opportunities for maximizing community pharmacists' impact.